Andrew joined OrbiMed in 2023 as a Managing Director on the Credit and Royalty team, focused on structured finance and royalty investments. Prior to joining OrbiMed, Andrew was an investment banker and led the Structured Finance practice at SVB Securities. Previously, Andrew was a Partner at MTS Health Partners. Andrew received a B.S. in Economics from the Wharton School at the University of Pennsylvania.
Ask Me About:
- Monetization of biopharmaceutical royalties and private credits
- Growing up in New York City